2001 -2002 Administrative Support, Marketing Department @ TargetRx
Michele Cunningham Education
Penn State University
BS (Marketing and International Business, International Studies)
Saint Joseph's University
MBA (Marketing)
Universidad de Salamanca
(International Studies and Spanish)
Archmere
Michele Cunningham Skills
Pharmaceutical Industry
Rare Diseases
Biotechnology
Cross-functional Team Leadership
Team Development
Professional Mentoring
Organizational Culture
Commercialization
Cross-functional Communication
International Business
International Studies
Strategic Planning
Portfolio Management
Product Launch Planning
Product Launch
Marketing Strategy
Marketing
Commercial Operations
Operational Excellence
Market Assessments
Market Development
Product Lifecycle Management
Brand Management
Positioning (Marketing)
Customer Segmentation Strategy
Brand Awareness
Patient Support
Patient Advocacy
Digital Marketing
Customer Relationship Management (CRM)
KOL Development
KPI Reporting
Market Research
Analytical Skills
Sales Operations
Sales Effectiveness
Sales Trainings
Managed Care
Business Development
Competitive Analysis
Due Diligence
Project Management
Biopharmaceuticals
Endocrinology
Neuromuscular
Pulmonology
CNS disorders
Neurology
Inhalation
Medical Devices
Michele Cunningham Summary
Michele Cunningham, based in Philadelphia, PA, US, is currently a Senior Vice President, Global Commercial Operations at Savara Inc.. Michele Cunningham brings experience from previous roles at Savara Inc., Xeris Pharmaceuticals, Inc., Strongbridge Biopharma plc (acquired by Xeris Pharmaceuticals) and Strongbridge Biopharma plc. Michele Cunningham holds a BS in Marketing and International Business, International Studies @ Penn State University. With a robust skill set that includes Pharmaceutical Industry, Rare Diseases, Biotechnology, Cross-functional Team Leadership, Team Development and more. Michele Cunningham has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Michele Cunningham?
Find contact details for 700 million professionals.